Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Fractyl Health, Inc. (GUTS : NSDQ)

• Company Description    Fractyl Health is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including T2D and obesity. Fractyl Health is based in Lexington, MA. Number of Employees: 100

• Price / Volume Information    Yesterday's Closing Price: $1.08 Daily Weekly Monthly 20 Day Moving Average: 1,069,550 shares Shares Outstanding: 13.26 (millions) Market Capitalization: $14.32 (millions) Beta: 2.42 52 Week High: $29.34 52 Week Low: $1.06 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -80.85% -80.65% 12 Week -86.96% -87.28% Year To Date -95.91% -96.18%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3 VAN DE GRAAFF DRIVE SUITE 200 - BURLINGTON,MA 01803 USA ph: 781-902-8800 fax: - ir@fractyl.com http://www.fractyl.com

• General Corporate Information    Officers Harith Rajagopalan - Chief Executive Officer and Director Lara Smith Weber - Chief Financial Officer and Treasurer Kelly Barnes - Director William W. Bradley - Director Samuel Conaway - Director Peer Information Fractyl Health, Inc. (GSAC) Fractyl Health, Inc. (CASIF) Fractyl Health, Inc. (ALCD.) Fractyl Health, Inc. (OMNN) Fractyl Health, Inc. (CGPI.) Fractyl Health, Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 35168W202 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/11/26 Share - Related Items Shares Outstanding: 13.26 Most Recent Split Date: 10.00 (0.08:1) Beta: 2.42 Market Capitalization: $14.32 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-1.64 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-6.32 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 37.23% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/11/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 77.36% vs. Previous Quarter: 7.69% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 09/30/26 - - 06/30/26 - -1,362.10 03/31/26 - -4,053.15 ROA 09/30/26 - - 06/30/26 - -84.89 03/31/26 - -96.41 Current Ratio 09/30/26 - - 06/30/26 - 3.15 03/31/26 - 4.28 Quick Ratio 09/30/26 - - 06/30/26 - 3.15 03/31/26 - 4.28 Operating Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Net Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Pre-Tax Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Book Value 09/30/26 - - 06/30/26 - -0.13 03/31/26 - 1.62 Inventory Turnover 09/30/26 - - 06/30/26 - - 03/31/26 - - Debt-to-Equity 09/30/26 - - 06/30/26 - - 03/31/26 - 1.41 Debt-to-Capital 09/30/26 - - 06/30/26 - - 03/31/26 - 58.50

Powered by Zacks Investment Research ©